J. Goldman & CO LP Abb Vie Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $3.23 Million - $3.74 Million	-24,185 Reduced 11.93%	178,591 $26.6 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $26.9 Million - $33.4 Million	202,776 New	202,776 $27.3 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $671,050 - $769,650	5,000 New	5,000 $671,000

3,808

1.27B

13M

9.94M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.